Leerink Partnrs Has Pessimistic View of Envista Q3 Earnings

Envista Holdings Co. (NYSE:NVST - Free Report) - Investment analysts at Leerink Partnrs reduced their Q3 2025 EPS estimates for Envista in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $0.26 per share for the quarter, down from their previous forecast of $0.30. Leerink Partnrs currently has a "Hold" rating on the stock. The consensus estimate for Envista's current full-year earnings is $1.06 per share. Leerink Partnrs also issued estimates for Envista's Q4 2025 earnings at $0.29 EPS, FY2025 earnings at $0.98 EPS and FY2026 earnings at $1.27 EPS.

Envista (NYSE:NVST - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%.

Several other research firms have also recently issued reports on NVST. Morgan Stanley raised their price target on shares of Envista from $19.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 6th. Stifel Nicolaus boosted their price target on Envista from $18.00 to $21.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Piper Sandler increased their price target on Envista from $17.00 to $18.00 and gave the stock a "neutral" rating in a research note on Monday, February 3rd. Mizuho initiated coverage on Envista in a research report on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 price objective for the company. Finally, Robert W. Baird increased their target price on Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Envista currently has an average rating of "Hold" and an average price target of $20.21.

Envista Price Performance

Shares of NVST traded down $0.19 during trading hours on Friday, reaching $21.04. 1,862,593 shares of the company traded hands, compared to its average volume of 2,266,592. The stock has a fifty day simple moving average of $19.91 and a 200 day simple moving average of $19.23. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $23.06. The stock has a market capitalization of $3.62 billion, a PE ratio of -3.24, a price-to-earnings-growth ratio of 2.06 and a beta of 1.34. The company has a quick ratio of 1.77, a current ratio of 2.04 and a debt-to-equity ratio of 0.44.

Institutional Trading of Envista

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Pacer Advisors Inc. increased its position in shares of Envista by 22.2% in the 3rd quarter. Pacer Advisors Inc. now owns 3,529,827 shares of the company's stock worth $69,749,000 after purchasing an additional 642,401 shares during the last quarter. Diamond Hill Capital Management Inc. increased its holdings in Envista by 8.1% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,335,710 shares of the company's stock valued at $26,394,000 after buying an additional 100,360 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in Envista by 138.5% in the third quarter. Harbor Capital Advisors Inc. now owns 404,589 shares of the company's stock valued at $7,995,000 after buying an additional 234,941 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Envista during the fourth quarter valued at approximately $53,000. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in Envista during the 3rd quarter worth approximately $14,965,000.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.